Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesmary Modugno

Showing results (61-70 of 203) with videos related to

Pageof 21
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2023
Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce Chemotherapy Resistance in Surrounding Cells in Response to ChemotherapyAlexander J Cole, Santiago Panesso-Gómez, Jaynish S Shah, et al.
Menopause (New York, N.Y.)|April 7, 2007
Mammographic density in a multiethnic cohortLaurel A Habel, Angela M Capra, Nina Oestreicher, et al.
Gynecologic Oncology|September 24, 2004
Analysis of CHEK2 gene for ovarian cancer susceptibilityBora E Baysal, Julie A DeLoia, Joan E Willett-Brozick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2014
Prognosis and conditional disease-free survival among patients with ovarian cancerMichelle L Kurta, Robert P Edwards, Kirsten B Moysich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Development of a multimarker assay for early detection of ovarian cancerZoya Yurkovetsky, Steven Skates, Aleksey Lomakin, et al.
Cancer Research|June 2, 2018
Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor MicroenvironmentMarie-Nicole Theodoraki, Saigopalakrishna Yerneni, Saumendra N Sarkar, et al.
Cancer Causes & Control : CCC|January 13, 2018
Anthropometric characteristics and ovarian cancer risk and survivalAlbina N Minlikeeva, Kirsten B Moysich, Paul C Mayor, et al.
Breast Cancer Research : BCR|August 8, 2015
The molecular landscape of premenopausal breast cancerSerena Liao, Ryan J Hartmaier, Kandace P McGuire, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 12, 2015
Use of common analgesics is not associated with ovarian cancer survivalAlbina N Minlikeeva, Jo L Freudenheim, Wei-Hsuan Lo-Ciganic, et al.
Cancer Causes & Control : CCC|August 30, 2003
Reproductive factors and ovarian cancer risk in Jewish BRCA1 and BRCA2 mutation carriers (United States)Francesmary Modugno, Roxana Moslehi, Roberta B Ness, et al.
Pageof 21

Showing results (61-70 of 203) with videos related to

Sort By:
Pageof 21
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2023
Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce Chemotherapy Resistance in Surrounding Cells in Response to ChemotherapyAlexander J Cole, Santiago Panesso-Gómez, Jaynish S Shah, et al.
Menopause (New York, N.Y.)|April 7, 2007
Mammographic density in a multiethnic cohortLaurel A Habel, Angela M Capra, Nina Oestreicher, et al.
Gynecologic Oncology|September 24, 2004
Analysis of CHEK2 gene for ovarian cancer susceptibilityBora E Baysal, Julie A DeLoia, Joan E Willett-Brozick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2014
Prognosis and conditional disease-free survival among patients with ovarian cancerMichelle L Kurta, Robert P Edwards, Kirsten B Moysich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Development of a multimarker assay for early detection of ovarian cancerZoya Yurkovetsky, Steven Skates, Aleksey Lomakin, et al.
Cancer Research|June 2, 2018
Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor MicroenvironmentMarie-Nicole Theodoraki, Saigopalakrishna Yerneni, Saumendra N Sarkar, et al.
Cancer Causes & Control : CCC|January 13, 2018
Anthropometric characteristics and ovarian cancer risk and survivalAlbina N Minlikeeva, Kirsten B Moysich, Paul C Mayor, et al.
Breast Cancer Research : BCR|August 8, 2015
The molecular landscape of premenopausal breast cancerSerena Liao, Ryan J Hartmaier, Kandace P McGuire, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 12, 2015
Use of common analgesics is not associated with ovarian cancer survivalAlbina N Minlikeeva, Jo L Freudenheim, Wei-Hsuan Lo-Ciganic, et al.
Cancer Causes & Control : CCC|August 30, 2003
Reproductive factors and ovarian cancer risk in Jewish BRCA1 and BRCA2 mutation carriers (United States)Francesmary Modugno, Roxana Moslehi, Roberta B Ness, et al.
Pageof 21